STOCK TITAN

Ionis to hold first quarter 2024 financial results webcast

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Ionis Pharmaceuticals, Inc. (IONS) will be holding a live webcast on May 7th, 2024, at 11:30 a.m. Eastern Time to discuss its first quarter financial results for 2024.
Ionis Pharmaceuticals, Inc. (IONS) terrà un webcast dal vivo il 7 maggio 2024, alle 11:30, ora della Costa Orientale, per discutere i risultati finanziari del primo trimestre del 2024.
Ionis Pharmaceuticals, Inc. (IONS) realizará una transmisión en vivo el 7 de mayo de 2024 a las 11:30 a.m. Hora del Este para discutir los resultados financieros del primer trimestre de 2024.
아이오니스 파마슈티컬스, Inc. (IONS)는 2024년 1분기 재무 결과를 논의하기 위해 동부 시간으로 2024년 5월 7일 오전 11시 30분에 생중계 웹캐스트를 개최할 예정입니다.
Ionis Pharmaceuticals, Inc. (IONS) organisera une webdiffusion en direct le 7 mai 2024 à 11h30, heure de l'Est, pour discuter des résultats financiers du premier trimestre de 2024.
Ionis Pharmaceuticals, Inc. (IONS) wird am 7. Mai 2024 um 11:30 Uhr Ostküstenzeit ein Live-Webcast abhalten, um über die Finanzergebnisse des ersten Quartals 2024 zu diskutieren.
Positive
  • None.
Negative
  • None.

Webcast scheduled for Tuesday, May 7 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., April 23, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Tuesday, May 7th at 11:30 a.m. Eastern Time to discuss its first quarter 2024 financial results.

The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – info@ionisph.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – CorporateCommunications@ionisph.com – 760-603-4679

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-first-quarter-2024-financial-results-webcast-302123806.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When is Ionis Pharmaceuticals, Inc. (IONS) hosting a live webcast to discuss its first quarter financial results for 2024?

Ionis Pharmaceuticals, Inc. (IONS) will be hosting a live webcast on May 7th, 2024, at 11:30 a.m. Eastern Time.

Where can the webcast be accessed?

The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events.

Will there be a replay available for the webcast?

Yes, a replay will be available for a time at the same web address.

What is the ticker symbol for Ionis Pharmaceuticals, Inc.?

The ticker symbol for Ionis Pharmaceuticals, Inc. is IONS.

Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Stock Data

5.19B
145.97M
0.78%
99.5%
6.26%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CARLSBAD